Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Gossypol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel synthetic route for high-purity gossypol via condensation and cyclization. Offers superior yield over extraction for pharmaceutical applications.
Patent CN112679319B reveals a scalable 8-step route to 1,1'-deoxygossypol from gossypol acetate, offering 45% yield and significant cost reduction in API manufacturing.
Patent CN111848374A details a streamlined 10-step asymmetric synthesis of high-purity gossypol enantiomers, offering significant cost reduction and scalability for API manufacturing.
Patent CN101883486B reveals non-chromatographic resolution. Enables cost reduction in pharmaceutical intermediate manufacturing via crystallization.
Patent CN105503627B reveals enhanced anticancer activity. Simplified synthesis offers supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing.
Discover the novel 8-step synthesis of 1,1'-deoxygossypol from gossypol acetate. Achieve 45% total yield with mild conditions for reliable pharmaceutical intermediate supply.